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Epstein–Barr virus (EBV) glycoprotein 110 (gp110) has sequence homology with herpes simplex virus-1 (HSV-1) gB;
however the role of gp110 in EBVs’ life cycle differs from that of gB. Unlike HSV-1 gB, which is essential for HSV-1 infection
but dispensable for virus production, gp110 is required for assembly and egress of EBV. EBV gp110 is found mainly in the
endoplasmic reticulum (ER)/nuclear membrane, whereas little or no gp110 is detected in the plasma membrane or a mature
viral particle. Conversely, HSV-1 gB is abundant in the envelope of mature virions and in the plasma membrane as well as
in the ER/nuclear membrane of HSV-1-infected cells. Interestingly, there are four consecutive arginine residues (at positions
836–839 of gp110) in the C-terminal domain previously shown to be important for gp110’s intracellular localization. To
determine whether these arginines function as an ER/nuclear localization signal, point mutants were constructed differen-
tially substituting the four arginines. The glycosylation pattern and intracellular localization of the mutants were investigated
by assessing sensitivity to endoglycosidase H (endo H) digestion and performing indirect immunofluorescence assays.
Substitution of part of the four arginines changed the glycosylation profile and targeting of gp110. In addition, mutations
preserving the net charge of the four arginines as well as those causing net charge shift resulted in the changed intracellular
localization and altered glycosylation pattern. These results suggest that not only the net charge but also the conformation
of the four arginines are important for gp110’s processing and subcellular localization. © 1999 Academic Press
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Epstein–Barr virus (EBV) glycoprotein 110 (gp110) is a
57-amino acid (aa) glycoprotein synthesized with a 22
a cleavable signal sequence at the amino terminal. It
onsists of a 663 aa ectodomain containing nine poten-
ial N-linked glycosylation sites followed by three hydro-
hobic segments with a putative transmembrane domain
nd a 104 aa C-terminal tail (Pellett et al., 1985). Previous
tudies have shown that gp110 is expressed during pro-
uctive infection period but not during latency (Kishishita
t al., 1984; Emini et al., 1987; Gong et al., 1987). The
unction of gp110 has been investigated actively since
he gene for gp110 was cloned and its sequence homol-
gy with herpes simplex virus-1 (HSV-1) gB was reported
n 1987 (Gong et al., 1987). The results obtained from
ymphoblastoid cell lines (LCLs) infected with gp110-null
utant EBV demonstrated that gp110 is essential either
or EBV entry or assembly but is dispensable for EBV-
riven proliferation of latently infected transformed B
ymphocytes (Herrold et al., 1996). In concordance, a
ecent electron microscopy study implicated gp110 in
BV assembly and/or budding as neither nucleocapsids
or enveloped virions were observed in any cellular
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350ompartments of lytically activated LCLs harboring
p110-null mutant EBV (Lee and Longnecker, 1997).
hese results are interesting in comparison with the role
f HSV-1 gB. HSV-1 gB, like EBV gp110, is also an es-
ential gene in its own viral life cycle. However, gB
unctions exclusively during viral entry while dispensable
n the process of production, assembly, and release of
SV-1 (Little et al., 1981; DeLuca et al., 1982; Cai et al.,
989). In accordance with their different roles, gp110 and
B also differ structurally. The mature 110-kDa gp110 has
ndo H-sensitive, high mannose, N-linked oligosaccha-
ides, indicating that gp110 does not traffic through Golgi
embranes (Gong and Kieff, 1990). This purely N-linked
orm is analogous to the immature form of HSV-1 gB but
ifferent from mature gB, which contains both N- and
-linked sugars (Wenske et al., 1982). Little or no EBV
p110 is detected in the virion or the plasma membrane
f infected cells but localizes predominantly in the inner
nd outer membranes of the nucleus and the endoplas-
ic reticulum (ER) (Gong and Kieff, 1990; Gong et al.,
987). In contrast, HSV-1 gB protein is an abundant
onstituent of the virion envelope and found in ER/nu-
lear membrane as well as in the plasma membrane of
nfected cells (Ali et al., 1987). The intracellular localiza-
ion of gp110 and gB support their different roles. HSV-1
B, required for viral entry to new host cells, is incorpo-ated in the viral envelope through budding from the
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351NLS FOR EBV gp110uclear membrane of infected cells (Stannard et al.,
996). On the other hand, gp110 plays an essential role in
he process of viral assembly, which takes place in the
ucleus where gp110 is abundantly expressed (Lee and
ongnecker, 1997).
Previous reports have shown that the C-terminal do-
ain, especially amino acids 817–841, of gp110 is impor-
ant for intracellular localization of gp110 using truncation
utants (Lee and Longnecker, 1997) and HSV-1 gB:EBV
p110 chimeric proteins (Lee et al., 1997). Contrary to
his, it has been reported that both the N- and C-terminal
omains of gp110 contain signals that are independently
ufficient to direct gp110 to the ER/nuclear membrane
Papworth et al., 1997). Presently, the mechanism for the
R/nuclear membrane localization of gp110 is not clearly
nderstood. Many ER or nuclear resident proteins con-
ain either ER retention signals or nuclear localization
ignals (NLSs) that are responsible for their proper tar-
eting. If gp110 contained an ER retention signal, it would
each the nuclear envelope membrane by diffusion after
t is made in the ER. However, gp110 does not contain the
lassical ER retention signal such as KDEL (Munro and
elham, 1987; Pelham, 1990). Most known NLSs have
omology to the sequence PKKKRKV found in SV-40
arge T antigen (Kalderon et al., 1984; Richardson et al.,
986; Burglin and De Robertis, 1987; Hauber et al., 1989;
ochrane et al., 1990). Other nuclear proteins use the
ipartite NLS usually consisting of two separate 3–4
onsecutive positively charged amino acid residues (An-
oine et al., 1997; Moore et al., 1998). Thus many proteins
tilize consecutively arranged positively charged amino
cids for their nuclear targeting. Interestingly, four con-
ecutive positively charged arginine residues are lo-
ated in the C-terminal domain of gp110 at amino acids
36–839 within the sequences previously found to be
mportant for gp110’s intracellular localization (Lee and
ongnecker, 1997; Lee et al., 1997, Papworth et al., 1997).
he four arginines may function as a NLS for gp110,
ausing its ER/nuclear membrane localization in infected
ells.
The purpose of the present study is to determine
hether the four consecutive arginine residues found in
he C-terminal domain of gp110 are the only important
equences for its ER/nuclear localization. To clarify this,
oint mutations were introduced to the arginine se-
uences of gp110, and each mutant was assayed for its
lycosylation pattern and intracellular localization.
RESULTS
onstruction of gp110 point mutants
To investigate the importance of the four consecutive
rginine residues at amino acids 836–839 for intracellu-
ar localization of gp110, four different point mutants with
ubstitutions at all or part of amino acids 836–839 were
onstructed (Fig. 1). A gp110 expression vector pSVgp110 tHerrold et al., 1996) was used as a template to introduce
oint mutations using QuickChange Site-Directed Mu-
agenesis Kit (Stratagene, La Jolla, CA) by following the
anufacturer’s instructions. Positive charges of the wild-
ype RRRR sequence were preserved after the mutation
n pSVgp110 (RKRR) and pSVgp110 (KKKK). In the other
wo point mutants, net charges were changed by amino
cid substitution: the two positively charged arginines at
osition 837 and 838 were replaced with negatively
harged glutamic acids in pSVgp110 (REER) or with neu-
ral threonines in pSVgp110 (RTTR).
xpression of gp110 point mutants in BJAB cells
The expression pattern of each gp110 point mutant
as studied in EBV-negative BJAB cells transfected with
ach expression construct. Following transfection the
ells were radiolabelled and immunoprecipitated with
he gp110-specific monoclonal antibody L2. Immunopre-
ipitated proteins were separated by SDS–PAGE (sodium
odecyl sulfate polyacrylamide gel electrophoresis). Fol-
owing electrophoresis, the gels were fixed and dried,
nd the immunoprecipitated proteins were visualized
ith autoradiography. As previously observed (Lee and
ongnecker, 1997; Lee et al., 1997), the major protein
mmunoprecipitated with L2 from cells transfected with
SVgp110 corresponded in size with the glycosylated
orm of gp110 at 110 kDa (Fig. 2, lane 1). From vector
ontrol (pSG5)-transfected cells, no immunoprecipitated
rotein was detected except nonspecific bands below
FIG. 1. Schematic representation of EBV gp110 and mutations
ntroduced into gp110. The coding region for EBV gp110 is represented
s an open box with gray areas indicating the three hydrophobic
omains. The numbers on top of the box indicate the numbers of gp110
mino acid. The C-terminal 6 amino acids at 835–840 of gp110 se-
uence, including four consecutive arginine residues marked by the
sterisks (****), and the corresponding cDNAs are illustrated. Point
utants used in this study are shown with the mutated amino acids
nderlined, and the substituted sequences on the cDNA shown in
ower-case letters.he 66-kDa size marker (Fig. 2, lane 6). The sizes of all
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352 SUK KYEONG LEEour point mutants were expected to be the same as that
f wild-type gp110. As expected, a protein band indistin-
uishable from wild-type gp110 was detected from cells
ransfected with each point mutant expression construct
Fig. 2, at 110 kDa position of lanes 2–5). However, a
ore slowly migrating diffuse protein band was detected
n addition to 110-kDa gp110 in cells transfected with
SVgp110(KKKK), pSVgp110(REER), or pSVgp110(RTTR)
Fig. 2, at 125 kDa position of lanes 3–5). These addi-
ional bands could represent differentially glycosylated
p110 due to a change in subcellular localization of the
oint mutants.
lycosylation patterns of the point mutant gp110s
To test whether the slowly migrating protein immuno-
recipitated with anti-gp110 monoclonal antibody as ob-
erved in Fig. 2 is gp110 with a changed glycosylation
attern, the mutant gp110s were treated with endo H
ollowing immunoprecipitation. As endo H specifically
leaves high-mannose N-linked oligosaccharides but not
omplex oligosaccharides, the resistance to endo H
reatment indicates that a glycoprotein is modified with
omplex sugars by processing through the Golgi appa-
atus. All carbohydrates were removed from wild-type
p110 using endo H, which resulted in a decrease of
FIG. 2. Immunoprecipitation of the mutated forms of gp110 in trans-
ected BJAB cells. BJAB cells were transfected with the indicated
lasmids, and labeled with [35S]methionine-cysteine for immunopre-
ipitation. Immunoprecipitated proteins from equivalent cell numbers
ere loaded in each lane and separated by SDS–PAGE. Gels were
ried and subjected to autoradiography. Molecular weight standards
re indicated at the left in kilodaltons. The locations of the slowly
igrating 125-kDa gp110 as well as the 110-kDa wild-type gp110 are
ndicated at the right.olecular mass to 93 kDa (Fig. 3. lane 2 vs lane 1), 1orresponding to the unmodified form of gp110 predicted
rom its amino acid composition (Gong et al., 1987).
hese data confirmed results obtained by other investi-
ators (Gong and Kieff, 1990; Papworth et al., 1997),
emonstrating that wild-type gp110 possesses mainly
igh-mannose-type glycosylation and that it is not further
odified by Golgi enzymes. A slight difference in migra-
ion of the endo-H-treated gp110 and gp110 produced
rom tunicamycin treated cells was noticeable (Fig. 3,
ane 2 vs lane 3). The difference would be due to the fact
hat endo H leaves the N-acetylglucosamine linker at
sparagine residues after digestion, while tunicamycin
locks the first step of glycosylation, causing no sugar
ddition on gp110 (Tarentino et al., 1974). Immunoprecipi-
ated gp110(RKRR) showed not only the same mobility
ut also the same deglycosylation pattern with endo H
reatment as wild-type gp110 (Fig. 3, lanes 4 and 5
ompared with lanes 1 and 2). These results suggest that
ubstituting arginine at position 837 with lysine did not
isturb the subcellular localization of gp110. On other
and, the results obtained from cells transfected with
SVgp110(KKKK), pSVgp110(REER), and pSVgp110(RTTR)
FIG. 3. Endoglycosidase H treatment of the mutated forms of gp110.
or the glycosylation analysis, the BJAB cells were transfected with the
ndicated plasmids and labeled with [35S] with or without tunicamycin
reatment. Twenty-four hours after transfection, the cells were har-
ested and subjected for immunoprecipitation as described in Fig. 2.
arts of the immunoprecipitated proteins were eluted and digested
ith endo H. Endo-H- (E) and mock-treated (U) samples were then
eparated together with tunicamycin treated (T) samples by SDS–PAGE
or further analysis as described in Fig. 2. Immunoprecipitated proteins
rom equivalent cell numbers were loaded in lanes for mock- and
ndo-H-treated samples while the proteins from approximately one-
hird of the cell numbers were loaded for tunicamycin treated samples
or SDS–PAGE. Molecular weight standards are indicated at the left in
ilodaltons. The locations of the slowly migrating 125-kDa, partially
eglycosylated 105 -kDa, and the nascent 93-kDa gp110 as well as the
10-kDa wild-type gp110 are indicated at the right.
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353NLS FOR EBV gp110ere similar to one another but different from those
btained from cells transfected with the wild-type gp110
xpression vector. As shown in Fig. 2, two distinct pro-
eins migrating with different mobility were visualized in
he untreated cells (Figs. 2, lanes 3–5, and 3, lanes 7, 10,
nd 13). The protein migrating at the same position as
ild-type gp110 was reduced in size to ;93 kDa with
ndo H treatment (Fig. 3, lanes 8, 11, and 14 at 93 kDa);
he reduction in size is evidence of its high mannose
ontent and lack of complex sugars. Contrary to this
esult, the band migrating slower than wild-type gp110
125 kDa) underwent a small mobility shift with endo H
igestion. This indicates that part of the mutant proteins
ere transported from the ER to Golgi and further mod-
fied with complex sugars (Fig. 3, lanes 8, 11, and 14 at
05 kDa).
ntracellular localization of the gp110 point mutant
roteins in B cells
To confirm that the changed glycosylation pattern and
obility on SDS–PAGE of the three point mutants,
SVgp110(KKKK), pSVgp110(REER), and pSVgp110(RTTR),
FIG. 4. Immunofluorescence microscopy of BJAB cells transfected
xpressed gp110 point mutants was studied 24 h after transfection with
nd live cell preparations.ere due to disturbed ER/nuclear membrane retention of cp110, the intracellular localization of the point mutants
as studied in a B cell line. At 24 h after transfection
ith each expression vector, BJAB cells were subjected
o indirect immunofluorescence assays. No reactivity
as observed in vector control transfected cells with
he L2 antibody (Fig. 4, pSG5). As previously reported
Lee and Longnecker, 1997; Lee et al., 1997), wild type
p110 was detected in fixed but not in live cell prepara-
ions using monoclonal antibody L2 indicating that
p110 was retained to the ER and nuclear membrane
Fig. 4, gp110). Likewise, gp110(RKRR) was detected in
ixed but not live cell preparations showing that arginine
o lysine substitution at position 837 did not disturb the
R/nuclear membrane localization pattern of gp110
Fig. 4). In contrast, gp110(KKKK), gp110(REER), and
p110(RTTR) were easily observed in both the live and
ixed cell preparations, implying that at least part of these
p110 mutants were expressed on the plasma mem-
rane of the transfected cells (Fig. 4). Thus the substitu-
ions made in these three mutants affected gp110’s sub-
ellular localization pattern in B cells, supporting the role
f the four arginine residues in gp110’s intracellular lo-
gp110 point mutant constructs. The intracellular localization of the
xpression vector by indirect immunofluorescence assays of both fixedwith
each ealization.
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354 SUK KYEONG LEEntracellular localization of the gp110 point mutant
roteins in epithelial cells
EBV infection of epithelial cells is detected in patho-
ogical conditions such as nasopharyngeal carcinoma
nd oral hairy leukoplakia as well as the ordinary infec-
ion cycle (Sixbey et al., 1984; De Souza et al., 1989;
eiss et al., 1989; Niedobitek et al., 1991). Thus to test
hether the four arginines in the C-terminal domain of
p110 function as a nuclear/ER targeting signal in epi-
helial cells as well as in B cells, immunofluorescence
tudies were performed. Two different epithelial cell
ines HeLa and SiHa were grown on 10-well slides. Cells
ere transfected with each expression vector using Li-
ofectamine reagent. Twenty-four hours posttransfec-
ion, cells were fixed and subjected to indirect immuno-
luorescence. Identical results were obtained from HeLa
nd SiHa cells and the results from HeLa cells are
FIG. 5. Immunofluorescence microscopy of HeLa cells transfecte
xpressed gp110 point mutants was studied in HeLa cells by indirect imhown on Fig. 5. No reactivity was observed in vector sontrol transfected cells with L2 antibody (Fig. 5, pSG5).
n cells transfected with wild-type gp110 or gp110(RKRR),
he staining pattern with L2 was rather small and round
onfined to the nuclear membrane with some staining of
ntracellular membranes consistent with ER/nuclear
embrane localization (Fig. 5). In contrast, the staining
attern with L2 was larger and irregular matching with
he HeLa cell’s elongated shape with pointed ends in
ells transfected with gp110(KKKK), gp110(REER), or
p110(RTTR) mutants (Fig. 5). These results show that
he subcellular localization of wild-type gp110 and mu-
ant gp110s in epithelial cells does not differ from that in
cells.
DISCUSSION
Previous efforts to clarify sequences of gp110 impor-
ant for its ER/nuclear membrane localization have
gp110 point mutant constructs. The intracellular localization of the
orescence assays, 24 h after transfection with each expression vector.d withhown disparate results. Some results imply that only the
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355NLS FOR EBV gp110-terminal domain of gp110 is important (Lee and Long-
ecker, 1997; Lee et al., 1997), whereas others suggest
hat both the N- and C-terminal domains can target
p110 to ER/nuclear membrane independently to each
ther (Papworth et al., 1997). In the C-terminal domain,
hich was shown to play a role in gp110’s subcellular
ocalization by all the previous results, four consecutive
rginine residues are found. Short stretches of positively
harged amino acids have been shown to function as
LS for various proteins (Kalderon et al., 1984; Richard-
on et al., 1986; Burglin and De Robertis, 1987; Hauber et
l., 1989; Cochrane et al., 1990; Antoine et al., 1997;
oore et al., 1998). The purpose of this study was to
nvestigate whether the four consecutive arginine resi-
ues found in the C-terminal domain of gp110 function as
LS for gp110.
Roughly half of the gp110(KKKK), gp110(REER), and
p110(RTTR) was detected at 125 kDa, whereas the re-
aining half was detected at 110 kDa on SDS–PAGE. The
25 kDa form of gp110 was partially resistant to endo H
igestion unlike the 110-kDa gp110, which was com-
letely digested to produce 93-kDa nascent gp110 (Gong
nd Kieff, 1990). This is unlikely to be a result of incom-
lete endo H digestion because the 110-kDa form of
p110 was completely digested under the same condi-
ions. Rather, the appearance of a more slowly migrating
25-kDa band of mutant gp110s is explained by acquisi-
ion of complex sugars in the Golgi apparatus. As ex-
ected, these mutant gp110s were detected in the
lasma membrane. These three gp110 mutants are very
imilar to HSV-1 gB and human cytomegalovirus (HCMV)
B in regard to their glycosylation pattern and intercel-
ular localization. Studies on HSV-1 gB and HCMV gB
ndicated that two distinct forms of wild-type gBs are
ound in cells infected with these viruses. One form is
odified with complex oligosaccharides, which are only
artially sensitive to endo H digestion, whereas the other
orm is glycosylated with endo-H-sensitive high man-
ose oligosaccharides (Britt and Vugler, 1989; Radsak et
l., 1990; Navarro et al., 1991, 1993). These results sug-
est that a proper structural configuration as well as the
ositive charge of the four arginine residues are required
or retention of gp110 in ER/nuclear membrane as the net
harge of gp110(KKKK) is conserved after mutation.
The RKRR sequence introduced in the gp110(RKRR)
utation is found in HSV-1 gB at the corresponding
ocation to RRRR of EBV gp110 (Pellet et al., 1985; Lee
nd Longnecker, 1997). HSV-1 gB is modified at a
ost-ER compartment and localizes in the plasma mem-
rane as well as in the ER/nuclear membrane of infected
ells (Wenske et al., 1982; Ali et al., 1987). The mutant
p110(RKRR) was indistinguishable from wild-type gp110
n terms of its endo H sensitivity and intracellular local-
zation as well as its mobility on SDS–PAGE. This indis-
inguishable mutant gp110 correlates with the results,
howing that the NLS of HSV-1 gB is not present on its e-terminal domain containing this RKRR sequence but
ound in the hydrophobic domain from amino acids 774–
95 (Gilbert et al., 1994). In HSV-1 gB, the RKRR se-
uence is present but other structural requirements for
hat sequence to function must not be present to explain
he different intracellular localization of HSV-1 gB com-
ared to EBV gp110. The results obtained from
p110(RKRR) together with the results from the other
hree point mutant gp110s suggest that although the four
rginine residues are important for gp110’s intracellular
ocalization, some other structural or configurational
roperties around this NLS may influence the protein’s
argeting. Further study is required to investigate the
haracteristics of gp110 important for its unique localiza-
ion.
In summary, the results obtained from the present
tudy indicate that mutation of the four arginines at
mino acids 836–839 within the C-terminal tail domain of
p110 is sufficient to change the intracellular transport
nd localization of gp110. Similar in gp110, consecutively
rranged arginines/lysines function as nuclear localiza-
ion signals in several viral proteins including human
mmunodeficiency virus tat and rev (Hauber et al., 1989;
ochrane et al., 1990), murine cytomegalovirus M44
ene product pp50 (Loh et al., 1999), and EBV nuclear
ntigen 2 (Cohen et al., 1991). As mentioned already,
apworth et al. (1997) identified sequences important for
uclear membrane localization and ER retention in the N-
nd C-terminal portion of gp110. In that study, gp110
runcation and chimeric proteins were expressed in a
abbit kidney epithelial cell line, RK13, infected with re-
ombinant vaccinina virus. The results presented in the
urrent study indicate that the N-terminal domain alone
oes not function as NLS for gp110 in B cells and some
pithelial cell lines. The differences observed in the two
tudies might be due to the absence of a specific cellular
actor present in the RK13 cells. Furthermore drastic
tructural change can cause misfolding of the protein
esulting in erroneous protein transport. Thus the results
btained from deletion mutants and chimeric proteins
hould be interpreted with caution.
The current study indicates the four arginines con-
ained within the gp110 C-terminal tail may interact with
pecific unknown cellular proteins to ensure retention of
p110 within the nuclear membrane and ER. Further
xperiments examining which cellular proteins interact
ith the C-terminal domain of gp110 and elucidation of
he 3-dimensional structure of gp110 will delineate how
he four arginines of gp110 function as a nuclear mem-
rane targeting signal.
MATERIALS AND METHODS
ell lines and cell culture
BJAB is an EBV-negative B-lymphoma cell line (Men-
zes et al., 1975). BJAB cells were maintained in RPMI
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356 SUK KYEONG LEE640 medium containing 10% inactivated fetal bovine
erum, 1000 U of penicillin/ml, and 1000 mg of strepto-
ycin (Sigma Chemical Co., St. Louis, MO) per milliliter.
eLa and SiHa are epithelial cell lines (Heiles et al.,
988). They were maintained in DMEM medium contain-
ng 10% inactivated fetal bovine serum, 1000 U of peni-
illin/ml, and 1000 mg of streptomycin (Sigma Chemical
o., St. Louis, MO) per milliliter.
onstruction of plasmids
A gp110 expression vector pSVgp110 (Herrold et al.,
996) was used as a template to introduce point muta-
ions using QuickChange Site-Directed Mutagenesis Kit
Stratagene, La Jolla, CA) by following the manufacturer’s
nstruction. The oligonucleotide sequences designed to
ntroduce point mutations are shown below with the
ucleotide sequences for R-836-R-837-R-838-R-839 un-
erlined and with the substituted sequences in lower-
ase letters: 59-CCAGGCCTACGCAaAAGACGCTATCAC-
ATCC-39 changed codon R-836 to K in pSVgp110(RKRR);
9-CGTTTTCCAGGCCTAaagAaAAaAaagTATCACGATCC-39
hanged codon R-836-R-837-R-838-R-839 to KKKK in
SVgp110(KKKK); 59-CCAGGCCTACGCgaAgaACGCTATCA-
GATCC-39 changed codon R-837-R-838 to EE in
SVgp110(REER); and 59-CCAGGCCTACGCAcAAcACGC-
ATCACGATCC-39 changed codon R-837-R-838 to TT in
SVgp110(RTTR). After mutagenesis the clones were se-
uenced by the dideoxy-chain termination method to con-
irm the authenticity (data not shown).
ransfections
Transfections into BJAB cells were performed by elec-
roporation as previously described (Lee and Long-
ecker, 1997). Briefly, 107 cells were resuspended in 400
l RPMI 1640 containing 10 mg of each plasmid and
lectroporated using a Gene Pulser electroporator (Bio-
ad Lab. Hercules, CA). Cells then were transferred to
5-cm2 flasks containing complete RPMI 1640 medium
nd incubated at 37°C in a 5% CO2 incubator.
Transfection into HeLa and SiHa cell lines were per-
ormed as previously reported with slight modification
Lee et al., 1997). Briefly, subconfluent epithelial cells
rown on 10-well glass slides were overlaid with purified
lasmid DNA and Lipofectamine Reagent (Gibco BRL,
aithersburg, MD) mixture in Opti-MEM (Gibco BRL,
aithersburg, MD). Following 5-h incubation at 37°C
fter transfection, the mixture was removed and com-
lete DMEM medium was added for further culture.
mmunoprecipitation of radiolabeled cells
The expression pattern of each gp110 point mutant
as studied in EBV negative BJAB cells transfected with
ach expression vector (Lee and Longnecker, 1997; Lee
t al., 1997). After transfection, cells were radiolabelled
ith [35S]methionine. Twenty-fours hour later, cells were rashed with phosphate-buffered saline (PBS) and lysed
n 1% N-P40 lysis buffer [1% Nonidet-P40, 50 mM Tris–
Cl (pH 7.4), 150 mM NaCl, 2 mM EDTA, 1 mg each
epstatin and leupeptin per ml, 0.5 mM phenylmethylsul-
onyl fluoride, 1 mM sodium orthovanadate]. The insolu-
le material was removed by centrifugation at 4°C.
leared lysates were immunoprecipitated with monoclo-
al antibody against gp110 (L2, Chemicon, Temecula,
A) for 1 h at 4°C and captured with protein G–Sepha-
ose. Samples were then washed four times in 1% N-P40
ysis buffer, mixed with equal volumes of 23 sodium
odecyl sulfate (SDS) sample buffer, incubated at 95°C
or 1 min, and separated by SDS-8% polyacrylamide gel
lectrophoresis (PAGE). Gels were fixed, dried, and sub-
ected to autoradiography.
lycosylation pattern analysis of the point mutant
p110s
For the glycosylation analysis of each gp110 point
utant, the BJAB cells were transfected with the indi-
ated plasmids and divided into two parts for control and
unicamycin treatment. Twenty micrograms per milliliter
unicamycin (Boehringer Mannheim, Mannheim, Ger-
any) was added to block glycosylation of proteins while
ehicle (dimetylformamide) was added for control exper-
ments at 1 h posttransfection. [35S]methionine (500 mCi/
l) was added to the media 1 h after tunicamycin/vehicle
reatment for labeling. Twenty-four hours after transfec-
ion, the cells were harvested and subjected for immu-
oprecipitation. The immunoprecipitated proteins from
he tunicamycin treated cells were kept frozen at 270°C
ntil SDS–PAGE analysis. The immunoprecipitated pro-
eins from the control cells were eluted and divided into
wo aliquots for endo H (Boehringer Mannheim, Mann-
eim, Germany) or mock digestion. Each aliquot was
ncubated for 16 h with 5 mU endo H/sample or water (for
ock digestion) at 30°C. Endo H and mock treated
amples were then separated together with tunicamycin
reated samples by SDS–PAGE for further analysis.
mmunofluorescence studies
BJAB cells were subjected for immunofluorescence
tudies 24 h after transfection with each expression
ector as previously described (Lee and Longnecker,
997; Lee et al., 1997). For the fixed-cell immunofluores-
ence, the cells were dried on glass slides, fixed with
cetone at 220°C for 5 min, blocked with 20% normal
oat serum for 10 min at room temperature, and incu-
ated with anti-EBV gp110 monoclonal antibody diluted
:1000 for 1 h. The cells were then incubated with an
nti-mouse fluorescein isothiocyanate (FITC) secondary
ntibody diluted 1:1000 and viewed with a fluorescence
icroscope. For the live-cell immunofluorescence, 1 ml
f BJAB cell suspension was pelleted in a tube and
esuspended in 20% normal goat serum containing anti-
g
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357NLS FOR EBV gp110p110 monoclonal antibody diluted 1:1000. Following in-
ubation on ice for 1 h with gentle agitation, the cells
ere washed twice, dried on glass slides, incubated with
n anti-mouse FITC secondary antibody, and viewed.
For epithelial cells, only fixed cells were used for
mmunofluorescence studies. HeLa or SiHa cells were
ultured for 24 h after transfection before used in immu-
ofluorescence studies. Cells were washed once with
BS, dried on a 37°C heating block, then fixed, blocked,
nd treated with antibodies for visualization as described
bove.
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